Efficacy and safety of the single-dose pegylated G-CSF vs. daily G-CSF for peripheral blood stem cells mobilization in donors: a multicenter, randomized controlled trial - Poll - MDSpire

Efficacy and safety of the single-dose pegylated G-CSF vs. daily G-CSF for peripheral blood stem cells mobilization in donors: a multicenter, randomized controlled trial

  • By

  • Jiali Li

  • Sha Zhou

  • Xiaoping Li

  • Xiangyu Ma

  • Sanbin Wang

  • Yicheng Zhang

  • Shifeng Lou

  • Jun Rao

  • Ping Wang

  • Lidan Zhu

  • Ting Chen

  • Xixi Xiang

  • Shichun Gao

  • Han Yao

  • Peiyan Kong

  • Lei Gao

  • Cheng Zhang

  • Xi Zhang

  • Li Gao

  • June 24, 2026

  • 0 min

Share

Original Source(s)

Efficacy and safety of the single-dose pegylated G-CSF vs. daily G-CSF for peripheral blood stem cells mobilization in donors: a multicenter, randomized controlled trial

  • by Jiali Li, Sha Zhou, Xiaoping Li, Xiangyu Ma, Sanbin Wang, Yicheng Zhang, Shifeng Lou, Jun Rao, Ping Wang, Lidan Zhu, Ting Chen, Xixi Xiang, Shichun Gao, Han Yao, Peiyan Kong, Lei Gao, Cheng Zhang, Xi Zhang, Li Gao

  • June 24, 2026

Related Content

Long-term trends in the burden of leukemia subtypes in China from 1990 to 2021: a Joinpoint regression and age-period-cohort analysis based on GBD 2021

Delays in Hematology Consultations and Non-Hematology Referrals in Blood Cancer Diagnosis: Insights from a Comprehensive National Survey in Australia

CRISPR Enables In Vivo CAR T Cell Production

In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing

  • March 30, 2026

  • 2 min